UPFRONT OVERALL SURVIVAL MODELLING IN COMPARISON TO REAL WORLD DATA: LENALIDOMIDE FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS IN SOUTH KOREA

被引:0
|
作者
Felix, J. [1 ]
Vandewalle, B. [1 ]
Almeida, J. [1 ]
Valeska, A. [1 ]
机构
[1] Exigo Consultores, Lisbon, Portugal
关键词
D O I
10.1016/j.jval.2014.08.073
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRM20
引用
收藏
页码:A729 / A729
页数:1
相关论文
共 50 条
  • [21] Modelling multiple myeloma using best clinical response to treatment to predict overall survival
    Irving, Adam
    Petrie, Dennis
    Fanning, Laura
    Harris, Anthony
    Spencer, Andrew
    Wood, Erica
    Wellard, Cameron
    Moore, Elizabeth
    Waters, Neil
    McQuilten, Zoe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S74 - S75
  • [22] SURVIVAL AND TREATMENT PATTERNS IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA (MM) IN A REAL-WORLD SETTING
    Hajek, R.
    Jarkovsky, J.
    Maisnar, V.
    Pour, L.
    Spicka, I.
    Minarik, J.
    Gregora, E.
    Kessler, P.
    Sykora, M.
    Frankova, H.
    Adamova, D.
    Wrobel, M.
    Mikula, P.
    Campioni, M.
    DeCosta, L.
    Treur, M.
    Gonzalez-McQuire, S.
    Bouwmeester, W.
    HAEMATOLOGICA, 2016, 101 : 529 - 529
  • [23] PATIENTS WITH MULTIPLE MYELOMA NOT CANDIDATES FOR TRANSPLANTATION: REAL WORLD DATA
    Sanchez-Raga, J. M.
    Perez-Montana, A.
    Beltran, N.
    Ros, T.
    Toledo, N.
    Sampol, A.
    HAEMATOLOGICA, 2018, 103 : 27 - 28
  • [24] It's the Response That Matters: Real-World Data of Multiple Myeloma Patients Treated without Upfront Stem Cell Transplant
    Lavu, Rohit Reddy
    Kumar, Lalit
    Velagapudi, Raja Mounika
    Konda, Sreenivas
    Arora, Shalabh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S433 - S433
  • [25] Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone
    San-Miguel, Jesus F.
    Dimopoulos, Meletios A.
    Stadtmauer, Edward A.
    Rajkumar, S. Vincent
    Siegel, David
    Bravo, Marie-Laure
    Olesnyckyj, Marta
    Knight, Robert D.
    Zeldis, Jerome B.
    Harousseau, Jean-Luc
    Weber, Donna M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01): : 38 - 43
  • [26] Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis
    Stork, Martin
    Spicka, Ivan
    Radocha, Jakub
    Minarik, Jiri
    Jelinek, Tomas
    Jungova, Alexandra
    Pavlicek, Petr
    Pospisilova, Lenka
    Sedlak, Frantisek
    Straub, Jan
    Pika, Tomas
    Knechtova, Zdenka
    Fidrichova, Anna
    Boichuk, Ivanna
    Sevcikova, Sabina
    Maisnar, Vladimir
    Hajek, Roman
    Pour, Ludek
    ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1501 - 1511
  • [27] OVERALL SURVIVAL IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA IN THE REAL-WORLD SETTING: A RETROSPECTIVE ANALYSIS OF THE PHAROS REGISTRY IN THE NETHERLANDS
    Verelst, S.
    Blommestein, H.
    Gonzalez-McQuire, S.
    DeCosta, L.
    de Raad, J.
    Sonneveld, P.
    Uyl-de Groot, C.
    HAEMATOLOGICA, 2016, 101 : 534 - 535
  • [28] REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA
    Ziff, M.
    Cheesman, S.
    Kyriakou, C.
    Mehta, A.
    Papanikolaou, X.
    Rabin, N.
    Wechalekar, A.
    Yong, K.
    Popat, R.
    HAEMATOLOGICA, 2017, 102 : 786 - 787
  • [29] Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
    Martin Stork
    Ivan Spicka
    Jakub Radocha
    Jiri Minarik
    Tomas Jelinek
    Alexandra Jungova
    Petr Pavlicek
    Lenka Pospisilova
    Frantisek Sedlak
    Jan Straub
    Tomas Pika
    Zdenka Knechtova
    Anna Fidrichova
    Ivanna Boichuk
    Sabina Sevcikova
    Vladimir Maisnar
    Roman Hajek
    Ludek Pour
    Annals of Hematology, 2023, 102 : 1501 - 1511
  • [30] Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma Post Autologous Stem Cell Transplant: A Comparison of Real-World Treatment Outcomes and Costs
    Hari, Parameswaran
    Ung, Brian
    Abouzaid, Safiya
    Ni, Quanhong
    Parikh, Kejal
    Agarwal, Amit
    BLOOD, 2017, 130